Trial intelligence / Profile preview

Long-term Safety and Efficacy of Lacosamide in Partial-Onset Seizures (EP0008 Extension, China)

CTR20131430Phase 3Active

Sponsor
UCB
Start
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of lacosamide in epilepsy, sponsored by UCB. Started Mar 2015; status: active.

02

Drugs

lacosamide
03

Conditions

epilepsy

Beyond the preview

Go deeper on CTR20131430.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131430.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call